Although IgG is the most utilised as an indicator of antibody-based immunity some studies also measured IgM (early-stage humoral immunity) and/or IgA (found in mucosal areas; IgA anti-VCA is more associated with nasopharyngeal carcinoma patients). Here, CD79A is linked to nasopharyngeal carcinoma.